Columbia University Medical Center has published new research that suggests that a hormone from the skeleton, osteocalcin, acts to systemically alter and influence blood sugar levels, potentially contributing to the onset of type 2 diabetes.
Already have a GenomeWeb or 360Dx account?Login Now.
In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.
The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.
Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.
In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.